Asia Pacific Radiopharmaceuticals Market

The Asia Pacific radiopharmaceuticals market consists of specialized medicinal compounds containing radioactive isotopes used for disease diagnosis and targeted therapy. Key customers include hospitals, clinics, and medical imaging centers. The market's growth is primarily driven by the increasing adoption of theranostics, which combines diagnostics and therapy, advancements in radioisotope production, and the integration of AI and automation into nuclear medicine workflows.